Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila

Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila

10.1523/JNEUROSCI.2375-09.2009

Saved in:

Bibliographic Details
Main Authors:	Ng, C.-H., Mok, S.Z.S., Koh, C., Ouyang, X., Fivaz, M.L., Tan, E.-K., Dawson, V.L., Dawson, T.M., Yu, F., Lim, K.-L.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/53081
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities
by: Wang, C., et al.
Published: (2014)

Thiol peroxidases ameliorateLRRK2mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila
by: Angeles, D.C., et al.
Published: (2016)

Inclusion body formation and neurodegeneration are parkin independent in a mouse model of ?-synucleinopathy
by: Von Coelln R., et al.
Published: (2018)

Parkin-mediated lysine 63-linked polyubiquitination: A link to protein inclusions formation in Parkinson's and other conformational diseases?
by: Lim, K.-L., et al.
Published: (2014)

Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function
by: Wang, C., et al.
Published: (2011)

Loss of locus coeruleus neurons and reduced startle in parkin null mice
by: Von Coelln R., et al.
Published: (2018)

Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin
by: Sriram S.R., et al.
Published: (2018)

Parkin ubiquitinates the ?-synuclein-interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease
by: Chung K.K.K., et al.
Published: (2018)

Modulation of sphingolipids, cholesterol and saturated fatty acids interact with the neurodegeneration in the Drosophila blue cheese mutant.
by: Boo, George.
Published: (2011)

The 350-fold compacted Fugu parkin gene is structurally and functionally similar to human Parkin
by: Yu, W.-P., et al.
Published: (2014)

Relative sensitivity of parkin and other cysteine-containing enzymes to stress-induced solubility alterations
by: Wong, E.S.P., et al.
Published: (2014)

Novel Monoclonal Antibodies Demonstrate Biochemical Variation of Brain Parkin with Age
by: Pawlyk A.C., et al.
Published: (2018)

Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: Implications for lewy body formation
by: Kah, L.L., et al.
Published: (2014)

MAP1B rescues LRRK2 mutant-mediated cytotoxicity
by: Chan S.L., et al.
Published: (2018)

Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
by: West A.B., et al.
Published: (2018)

AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease
by: Ng, C.-H., et al.
Published: (2014)

Dysregulated dopamine metabolism in LRRK2 mutants
by: Chia, Xin Tian
Published: (2015)

Optogenetic stimulation of a subset of dopaminergic neurons in drosophila
by: Chong, Melissa Hui Yan
Published: (2017)

LRRK2 G2019S founder haplotype in the Chinese population
by: Tan E.-K., et al.
Published: (2018)

Molecular interactions between Parkin and FBXO7 and links with induced dopaminergic neuron degeneration in Parkinson's disease.
by: Tang, Alyssa Meiyan.
Published: (2013)

The genetics of Parkinson's disease.
by: Lim K.L., et al.
Published: (2018)

The cast of molecular characters in Parkinson's disease: Felons, conspirators, and suspects
by: Lim K.L., et al.
Published: (2018)

Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease
by: Chen Z.-C., et al.
Published: (2018)

Fully automated leg tracking of drosophila neurodegeneration models reveals distinct conserved movement signatures
by: Wu, S., et al.
Published: (2021)

AF-6 protects against dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson’s disease
by: Basil A.H., et al.
Published: (2018)

Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson's disease
by: Nada Saewanee, et al.
Published: (2022)

SEPT5_v2 is a parkin-binding protein
by: Choi P., et al.
Published: (2018)

Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations
by: Wang, C., et al.
Published: (2014)

IDENTIFICATION OF ALPHA-SYNUCLEIN DOMINANT MODIFIERS IN A DROSOPHILA MODEL OF NEURODEGENERATION
by: REN MENGDA
Published: (2020)

Parkin regulation and neurodegenerative disorders
by: Zhang C.-W., et al.
Published: (2018)

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
by: Tan E.K., et al.
Published: (2018)

Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults
by: Hyun, D.-H., et al.
Published: (2011)

DAMPs and neurodegeneration
by: Thundyil J., et al.
Published: (2018)

Effect of wild-type or mutant parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome
by: Hyun, D.-H., et al.
Published: (2013)

CENTRAL DOPAMINERGIC INSUFFICIENCY IN HYPERTENSION
by: JOSEPHINE MOK SHIUEH LIAN
Published: (2020)

Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant α-synuclein
by: Zhou, Z.D., et al.
Published: (2014)

Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons
by: Zhou, Zhidong, et al.
Published: (2022)

Reactive oxygen species trigger Parkin/PINK1 pathway-dependent mitophagy by inducing mitochondrial recruitment of Parkin
by: Xiao B., et al.
Published: (2018)

Mitophagy and neurodegeneration
by: Lim K.-L., et al.
Published: (2018)

Neuronal PAS domain protein 1 regulates tyrosine hydroxylase level in dopaminergic neurons
by: Teh, C.H.L., et al.
Published: (2014)